Oncology & Cancer

Silencing RNA nanotherapy shows promise against pancreatic cancer

Despite advances in cancer survival, more than 90 percent of people with pancreatic cancer die within five years. Most patients with pancreatic tumors (and half of those with colorectal cancers) carry a mutation in the KRAS ...

Medical research

Microbiome: Untapped source of novel antimicrobials

Just as Gold Rush prospectors once mined the Northern California hills for the shiny precious metal, "bioprospectors" are searching for a new prize: potential antimicrobial molecules—and they are hunting them down in the ...

Oncology & Cancer

Chemists study new cancer therapies

For the last 10 years, Edith (Phoebe) Glazer, an associate professor of biological chemistry in the University of Kentucky College of Arts and Sciences, has focused on creating new cancer therapies. As an inorganic chemist, ...

page 1 from 11